TME Pharma N.V. (EPA:ALTME)
France
· Delayed Price · Currency is EUR 0.0725
-0.0005 (-0.68%)
May 16, 2025, 5:28 PM CET
TME Pharma Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 3.24 | 2.25 | 4.63 | 9.46 | 10.3 | Upgrade
|
| Short-Term Investments | 0.01 | - | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 3.25 | 2.25 | 4.63 | 9.46 | 10.3 | Upgrade
|
| Cash Growth | 44.54% | -51.55% | -50.99% | -8.23% | 643.97% | Upgrade
|
| Other Receivables | 0.03 | 0.04 | 0.28 | 0.08 | 0.07 | Upgrade
|
| Receivables | 0.03 | 0.04 | 0.28 | 0.08 | 0.07 | Upgrade
|
| Prepaid Expenses | 0.07 | 0.08 | 0.06 | 0.1 | 0.09 | Upgrade
|
| Restricted Cash | 0.01 | 0.01 | 0.01 | 0.03 | 0.03 | Upgrade
|
| Other Current Assets | 0.01 | 0.01 | 0.02 | 0.03 | 0.03 | Upgrade
|
| Total Current Assets | 3.36 | 2.39 | 5.01 | 9.69 | 10.53 | Upgrade
|
| Property, Plant & Equipment | 0.03 | 0.1 | 0.22 | 0.07 | 0.12 | Upgrade
|
| Long-Term Investments | 0.01 | 0.01 | - | - | - | Upgrade
|
| Other Intangible Assets | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Other Long-Term Assets | - | - | 0.01 | 0.01 | 0.01 | Upgrade
|
| Total Assets | 3.41 | 2.49 | 5.24 | 9.77 | 10.65 | Upgrade
|
| Accounts Payable | 1.33 | 1.17 | 1.7 | 2.24 | 1.8 | Upgrade
|
| Accrued Expenses | 0.4 | 0.33 | 0.48 | 0.48 | 0.43 | Upgrade
|
| Current Portion of Long-Term Debt | - | 1.1 | 3.91 | 2.42 | 0.55 | Upgrade
|
| Current Portion of Leases | - | 0.07 | 0.11 | 0.02 | 0.05 | Upgrade
|
| Other Current Liabilities | 0.06 | 0.12 | 0.25 | 0.11 | 0.07 | Upgrade
|
| Total Current Liabilities | 1.79 | 2.79 | 6.45 | 5.27 | 2.9 | Upgrade
|
| Long-Term Debt | - | - | - | - | 0.04 | Upgrade
|
| Long-Term Leases | - | - | 0.07 | - | 0.02 | Upgrade
|
| Total Liabilities | 1.79 | 2.79 | 6.51 | 5.27 | 2.96 | Upgrade
|
| Common Stock | 0.94 | 0.17 | 1.74 | 0.75 | 0.47 | Upgrade
|
| Additional Paid-In Capital | 200.98 | 194.12 | 184.84 | 176.46 | 165.48 | Upgrade
|
| Retained Earnings | -200.09 | -194.37 | -187.64 | -172.5 | -158.05 | Upgrade
|
| Treasury Stock | -0.23 | -0.22 | -0.22 | -0.19 | -0.19 | Upgrade
|
| Comprehensive Income & Other | 0.01 | 0.01 | 0.01 | 0.01 | - | Upgrade
|
| Total Common Equity | 1.61 | -0.29 | -1.27 | 4.52 | 7.71 | Upgrade
|
| Minority Interest | - | - | - | -0.01 | -0.01 | Upgrade
|
| Shareholders' Equity | 1.61 | -0.29 | -1.27 | 4.5 | 7.7 | Upgrade
|
| Total Liabilities & Equity | 3.41 | 2.49 | 5.24 | 9.77 | 10.65 | Upgrade
|
| Total Debt | - | 1.17 | 4.09 | 2.44 | 0.65 | Upgrade
|
| Net Cash (Debt) | 3.25 | 1.08 | 0.55 | 7.02 | 9.65 | Upgrade
|
| Net Cash Growth | 200.74% | 96.90% | -92.19% | -27.30% | 668.39% | Upgrade
|
| Net Cash Per Share | 0.09 | 0.21 | 0.47 | 10.63 | 29.83 | Upgrade
|
| Filing Date Shares Outstanding | 94.11 | 17.28 | 1.72 | 0.84 | 0.47 | Upgrade
|
| Total Common Shares Outstanding | 94.11 | 17.28 | 1.72 | 0.75 | 0.47 | Upgrade
|
| Working Capital | 1.57 | -0.4 | -1.44 | 4.43 | 7.63 | Upgrade
|
| Book Value Per Share | 0.02 | -0.02 | -0.74 | 6.06 | 16.37 | Upgrade
|
| Tangible Book Value | 1.61 | -0.3 | -1.28 | 4.51 | 7.71 | Upgrade
|
| Tangible Book Value Per Share | 0.02 | -0.02 | -0.74 | 6.05 | 16.36 | Upgrade
|
| Machinery | 0.32 | 0.36 | 0.35 | 0.36 | 0.35 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.